A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus. (2019)

First Author: Fawsitt CG
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2018.12.011

PubMed Identifier: 31198187

Publication URI: http://europepmc.org/abstract/MED/31198187

Type: Journal Article/Review

Volume: 22

Parent Publication: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Issue: 6

ISSN: 1098-3015